DE59804696D1 - CELL-SPECIFIC RETROVIRAL VECTORS WITH ANTIBODY DOMAINS AND METHOD FOR THEIR PRODUCTION FOR SELECTIVE GENE TRANSFER - Google Patents

CELL-SPECIFIC RETROVIRAL VECTORS WITH ANTIBODY DOMAINS AND METHOD FOR THEIR PRODUCTION FOR SELECTIVE GENE TRANSFER

Info

Publication number
DE59804696D1
DE59804696D1 DE59804696T DE59804696T DE59804696D1 DE 59804696 D1 DE59804696 D1 DE 59804696D1 DE 59804696 T DE59804696 T DE 59804696T DE 59804696 T DE59804696 T DE 59804696T DE 59804696 D1 DE59804696 D1 DE 59804696D1
Authority
DE
Germany
Prior art keywords
cell
retroviral vectors
production
specific
gene transfer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE59804696T
Other languages
German (de)
Inventor
Klaus Cichutek
Martin Engelstaedter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BUNDESREPUBLIK DEUTSCHLAND LET
Paul-Ehrlich-Institut
Original Assignee
BUNDESREPUBLIK DEUTSCHLAND LET
Paul-Ehrlich-Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BUNDESREPUBLIK DEUTSCHLAND LET, Paul-Ehrlich-Institut filed Critical BUNDESREPUBLIK DEUTSCHLAND LET
Application granted granted Critical
Publication of DE59804696D1 publication Critical patent/DE59804696D1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2881—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD71
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13045—Special targeting system for viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
    • C12N2810/80—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates
    • C12N2810/85—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian
    • C12N2810/859—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian from immunoglobulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention relates to cell-specific retroviral vectors with antibody recognition domains (scFv), which are suitable for cell-specific transduction of a selected mammal cell type (cell targeting), to methods for the production of the cell-specific retroviral vectors and to the use thereof in gene transfers into selected cells. The invention further relates to retroviral packaging cells to obtain cell-specific vectors according to the present invention.
DE59804696T 1997-11-28 1998-11-27 CELL-SPECIFIC RETROVIRAL VECTORS WITH ANTIBODY DOMAINS AND METHOD FOR THEIR PRODUCTION FOR SELECTIVE GENE TRANSFER Expired - Fee Related DE59804696D1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19752854A DE19752854C2 (en) 1997-11-28 1997-11-28 Cell-specific retroviral vectors with antibody domains and methods for their production for selective gene transfer
PCT/DE1998/003543 WO1999028489A2 (en) 1997-11-28 1998-11-27 Cell-specific retroviral vectors with antibody domains and method for the production thereof for selective gene transfer

Publications (1)

Publication Number Publication Date
DE59804696D1 true DE59804696D1 (en) 2002-08-08

Family

ID=7850144

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19752854A Expired - Fee Related DE19752854C2 (en) 1997-11-28 1997-11-28 Cell-specific retroviral vectors with antibody domains and methods for their production for selective gene transfer
DE59804696T Expired - Fee Related DE59804696D1 (en) 1997-11-28 1998-11-27 CELL-SPECIFIC RETROVIRAL VECTORS WITH ANTIBODY DOMAINS AND METHOD FOR THEIR PRODUCTION FOR SELECTIVE GENE TRANSFER

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE19752854A Expired - Fee Related DE19752854C2 (en) 1997-11-28 1997-11-28 Cell-specific retroviral vectors with antibody domains and methods for their production for selective gene transfer

Country Status (7)

Country Link
US (1) US7531322B2 (en)
EP (1) EP1034292B1 (en)
AT (1) ATE220106T1 (en)
AU (1) AU2149199A (en)
CA (1) CA2311602C (en)
DE (2) DE19752854C2 (en)
WO (1) WO1999028489A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19946142A1 (en) * 1999-09-27 2001-03-29 Bundesrepublik Deutschland Let Cell-targeting vector selective for T lymphocytes, useful in gene therapy of e.g. acquired immune deficiency syndrome, encodes a single-chain variable antibody fragment
DE10218129A1 (en) * 2002-04-23 2003-11-20 Univ Ruprecht Karls Heidelberg Genetic vaccine against RNA virus infections

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4642291A (en) * 1982-09-01 1987-02-10 Sloan-Kettering Institute For Cancer Research Cell surface antigens of human astrocytoma
US6352694B1 (en) * 1994-06-03 2002-03-05 Genetics Institute, Inc. Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells
DE4122599C2 (en) * 1991-07-08 1993-11-11 Deutsches Krebsforsch Phagemid for screening antibodies
CA2149889A1 (en) * 1992-11-20 1994-06-09 Ralph C. Dornburg Cell-type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins
US5869331A (en) * 1992-11-20 1999-02-09 University Of Medicine & Dentistry Of New Jersey Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins
CA2184354A1 (en) * 1994-03-04 1995-09-08 Ralph C. Dornburg Cell-type specific gene transfer using retroviral vectors containing antibody-envelope and wild-type envelope-fusion proteins
WO1996030504A1 (en) 1995-03-24 1996-10-03 Genetic Therapy, Inc. Modified viral envelope polypeptide

Also Published As

Publication number Publication date
CA2311602C (en) 2007-04-03
WO1999028489A3 (en) 1999-07-22
EP1034292B1 (en) 2002-07-03
CA2311602A1 (en) 1999-06-10
WO1999028489A9 (en) 1999-09-10
AU2149199A (en) 1999-06-16
DE19752854C2 (en) 2000-07-06
WO1999028489A2 (en) 1999-06-10
US20050191740A1 (en) 2005-09-01
US7531322B2 (en) 2009-05-12
ATE220106T1 (en) 2002-07-15
EP1034292A2 (en) 2000-09-13
DE19752854A1 (en) 1999-07-01

Similar Documents

Publication Publication Date Title
DE59812625D1 (en) Retroviral PSEUDOTYPE VECTORS WITH MODIFIED SURFACE-WRAPPING PROTEINS AND METHOD FOR THE PRODUCTION THEREOF OF THE SELECTIVE TRANSFER OF GRAIN
ATE64151T1 (en) RECOMBINANT IMMUNOGLOBULIN PREPARATIONS, METHODS FOR THEIR PRODUCTION, DNA SEQUENCES, EXPRESSION VECTORS AND RECOMBINANT ACTIVE CELLS THEREOF.
DE69434578D1 (en) Expression vectors encoding bispecific proteins, and methods of producing biologically active bispecific fusion proteins in mammalian cells
ATE2965T1 (en) CELL LINES, METHODS FOR THEIR PRODUCTION AND METHODS FOR PRODUCTION OF ANTIBODIES.
LU91756I2 (en) denosumab
DE69623057T2 (en) RECOMBINATORY CLONING IN VITRO USING GENE-manipulated RECOMBINATION LOCATIONS
DE59401483D1 (en) GRAFTED POLYAMIDOAMINE AND GRAFTED POLYETHYLENIMINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS AN ADDITIONAL DETERGENT
DE3675567D1 (en) REINFORCED RUBBER BLENDS, METHOD FOR THEIR PRODUCTION AND THEIR USE.
DK1546327T3 (en) Selection and isolation of living cells using RNA binding probes
DE50115587D1 (en) Process for the preparation of protein libraries and for the selection of proteins from them
ATA208987A (en) IMMORTALIZED CELL LINE, METHOD FOR THEIR PRODUCTION AND METHOD FOR THE PRODUCTION OF MONOCLONAL ANTIBODIES, AND DIAGNOSTIC METHODS AND MEANS
DE69837744D1 (en) Nonaqueous electrolyte secondary battery and process for its production
AR014891A1 (en) ISOLATED GENES OF MAMPHERE MEMBRANE PROTEINS; RELATED REAGENTS
BR9912455A (en) nucleic acids encoding proteins involved in sensory transduction
ATE315658T1 (en) GENETIC CONSTRUCTS FOR GENIMUNIZATION
ATE279443T1 (en) A3C6E2, A MONOCLONAL ANTIBODY SPECIFIC TO THE HUMAN STEM CELL FACTOR (SCF) RECEPTOR
CA2306449A1 (en) Rapid generation of stable mammalian cell lines producing high levels of recombinant proteins
WO1998024906A3 (en) Isolated mammalian monocyte cell genes; related reagents
ATE428803T1 (en) EXPRESSION OF P2Y-PURINERGEM RECEPTOR TO IDENTIFY PRENEOPLASTIC AND NEOPLASTIC CONDITIONS
ATE387493T1 (en) GENES ENCODING PROTEINS WITH TRANSGLYCOLYZING ACTIVITY.
DE59804696D1 (en) CELL-SPECIFIC RETROVIRAL VECTORS WITH ANTIBODY DOMAINS AND METHOD FOR THEIR PRODUCTION FOR SELECTIVE GENE TRANSFER
DE69108160D1 (en) Fuel electrodes for solid oxide fuel cells and process for their manufacture.
DE3575570D1 (en) DISAZO CONNECTIONS, METHOD FOR THEIR PRODUCTION AND THEIR USE.
WO1989009824A3 (en) Gene synthesis
DE59707813D1 (en) RECEPTOR BINDING ASSAY, RECOMBINANT FUSION RECEPTOR SUITABLE FOR THE RECEPTOR BINDING ASSAY, VECTOR FOR THEIR PRODUCTION AND REAGENT SET FOR IMPLEMENTING THE RECEPTOR BINDING ASSAY

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee